Achieve Life Sciences Receivables

Achieve Life Sciences (ACHV) currently reports a receivables of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Achieve Life Sciences's receivables history and peer comparisons.

Achieve Life Sciences's receivables changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Achieve Life Sciences reported $0 in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Achieve Life Sciences, and consider following ACHV for alerts when major investors trade the stock.

Achieve Life Sciences is classified in the Technology sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing ACHV with unrelated industries.